Doyle Wealth Management Astrazeneca PLC Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Doyle Wealth Management holds 4,494 shares of AZN stock, worth $344,195. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,494

Previous 4,226 6.34%

Holding current value

$344,195

Previous $279,000 11.83%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $14,209 - $36,381	268 Added 6.34%	4,494 $246,000
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $86,875 - $104,291	-1,466 Reduced 25.76%	4,226 $279,000
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $13,317 - $16,041	-239 Reduced 4.03%	5,692 $378,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $30,575 - $36,127	-566 Reduced 8.71%	5,931 $345,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $6,833 - $7,477	-123 Reduced 1.86%	6,497 $390,000
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $63,430 - $78,835	-1,310 Reduced 16.52%	6,620 $397,000
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $920,704 - $1.06 Million	-19,523 Reduced 71.11%	7,930 $394,000
Q4 2020 Feb 04, 2021	SELL	$48.52 - $58.02 $200,969 - $240,318	-4,142 Reduced 13.11%	27,453 $1.37 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $159 - $183	-3 Reduced 0.01%	31,595 $1.73 Million
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $12,412 - $15,929	288 Added 0.92%	31,598 $1.67 Million
Q1 2020 Apr 29, 2020	SELL	$37.79 - $51.33 $85,367 - $115,954	-2,259 Reduced 6.73%	31,310 $1.4 Million
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $46,960 - $55,808	1,106 Added 3.41%	33,569 $1.67 Million
Q3 2019 Nov 05, 2019	BUY	$40.12 - $45.47 $14,362 - $16,278	358 Added 1.12%	32,463 $1.45 Million
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $10,363 - $11,587	278 Added 0.87%	32,105 $1.33 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $82,088 - $99,505	2,313 Added 7.84%	31,827 $1.2 Million
Q4 2018 Feb 08, 2019	BUY	$36.86 - $41.49 $122,964 - $138,410	3,336 Added 12.74%	29,514 $1.12 Million
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $54,434 - $62,201	1,566 Added 6.36%	26,178 $1.04 Million
Q2 2018 Aug 08, 2018	BUY	$34.55 - $37.05 $850,344 - $911,874	24,612 New	24,612 $864,000

Others Institutions Holding AZN

# of Institutions

1,422

Shares Held

505M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $237B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Astrazeneca PLC Transaction History